Innovative approaches to integrating biomedical and behavioral science are at the cutting edge of HIVprevention and treatment. To be effective, the most promising biomedical interventions will requirebehavioral expertise -- predicated on research that incorporates the social and community context. The valueof behavioral research is in turn leveraged by the integration of biological interventions and outcomes. TheSociobehavioral and Prevention Research Core (SPRC) facilitates such collaborations among social,behavioral and clinical scientists working on HIV at the UW. In its inaugural cycle, the SPRC was highlysuccessful in meeting its core aims of providing technical assistance, sponsoring public education events,publishing state-of-the-art reviews, and establishing new investigators in the areas of (1) preventionintervention studies, (2) clinical adherence research, and (3) modeling HIV transmission dynamics andpartnership networks. In addition, the core established five new institutional mechanisms for collaborativeresearch and practice. In this renewal we have refined our aims to focus on (1) HIV prevention researchsupport, and (2) community outreach for translation of research findings into practice. The new synergisticaims build on our original strengths, reflect our evolving direction, and extend our capacity in the emergingareas of biomedical prevention interventions and community-based participatory research. Specifically, thefirst aim of HIV prevention research support comprises the provision of technical assistance and organizationof forums for interdisciplinary research community development, with a new focus on expanding substantiveexpertise in substance use, mental health, and qualitative methods.
The second aim of supportingcommunity outreach involves working globally. Locally, we are proposing a new Community Outreachsubcore to facilitate collaboration with our Community Action Board and the Seattle/King County PublicHealth Department on community-based research priorities and translational opportunities. Internationally,we have formalized links to the International Core to identify collaborative research and translationalopportunities and established a new NIH-funded Center on HIV Prevention Research at the University ofNairobi.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
2P30AI027757-21
Application #
7479037
Study Section
Special Emphasis Panel (ZAI1-EC-A (J1))
Project Start
2008-06-01
Project End
2013-05-31
Budget Start
2008-06-01
Budget End
2009-05-31
Support Year
21
Fiscal Year
2008
Total Cost
$171,426
Indirect Cost
Name
University of Washington
Department
Type
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Torres, Thiago S; Harrison, Linda J; La Rosa, Alberto M et al. (2018) Quality of life improvement in resource-limited settings after one year of second-line antiretroviral therapy use among adult men and women. AIDS 32:583-593
Altekruse, Sean F; Shiels, Meredith S; Modur, Sharada P et al. (2018) Cancer burden attributable to cigarette smoking among HIV-infected people in North America. AIDS 32:513-521
Patel, Rena C; Bukusi, Elizabeth A; Baeten, Jared M (2018) Current and future contraceptive options for women living with HIV. Expert Opin Pharmacother 19:1-12
Ross, Jennifer M; Ying, Roger; Celum, Connie L et al. (2018) Modeling HIV disease progression and transmission at population-level: The potential impact of modifying disease progression in HIV treatment programs. Epidemics 23:34-41
Wagner, Anjuli D; Shah, Seema K; Njuguna, Irene N et al. (2018) Financial Incentives to Motivate Pediatric HIV Testing-Assessing the Potential for Coercion, Inducement, and Voluntariness. J Acquir Immune Defic Syndr 78:e15-e18
Stekler, Joanne D; Milne, Ross; Payant, Rachel et al. (2018) Transmission of HIV-1 drug resistance mutations within partner-pairs: A cross-sectional study of a primary HIV infection cohort. PLoS Med 15:e1002537
Smith, Robert A; Wu, Vincent H; Zavala, Christopher G et al. (2018) In Vitro Antiviral Activity of Cabotegravir against HIV-2. Antimicrob Agents Chemother 62:
Stekler, Joanne D; Violette, Lauren R; Niemann, Lisa et al. (2018) Repeated False-Positive HIV Test Results in a Patient Taking HIV Pre-Exposure Prophylaxis. Open Forum Infect Dis 5:ofy197
Golob, Jonathan L; Stern, Joshua; Holte, Sarah et al. (2018) HIV DNA levels and decay in a cohort of 111 long-term virally suppressed patients. AIDS 32:2113-2118
Katz, David A; Golden, Matthew R; Hughes, James P et al. (2018) HIV Self-Testing Increases HIV Testing Frequency in High-Risk Men Who Have Sex With Men: A Randomized Controlled Trial. J Acquir Immune Defic Syndr 78:505-512

Showing the most recent 10 out of 1275 publications